177 related articles for article (PubMed ID: 34392112)
21. Drug checking services as a surveillance tool for clinical laboratories: Examining trends in the unregulated fentanyl supply.
Delaney SR; Konforte D; Stefan C; Palaty J; Sun D; McDonald K; Thompson H; Werb D; Beriault DR
Clin Biochem; 2023 Jan; 111():11-16. PubMed ID: 36379241
[TBL] [Abstract][Full Text] [Related]
22. Targeted and untargeted detection of fentanyl analogues and their metabolites in hair by means of UHPLC-QTOF-HRMS.
Salomone A; Di Corcia D; Negri P; Kolia M; Amante E; Gerace E; Vincenti M
Anal Bioanal Chem; 2021 Jan; 413(1):225-233. PubMed ID: 33063167
[TBL] [Abstract][Full Text] [Related]
23. Xylazine detected in unregulated opioids and drug administration equipment in Toronto, Canada: clinical and social implications.
Bowles JM; McDonald K; Maghsoudi N; Thompson H; Stefan C; Beriault DR; Delaney S; Wong E; Werb D
Harm Reduct J; 2021 Oct; 18(1):104. PubMed ID: 34645480
[TBL] [Abstract][Full Text] [Related]
24. Drug checking as a potential strategic overdose response in the fentanyl era.
Laing MK; Tupper KW; Fairbairn N
Int J Drug Policy; 2018 Dec; 62():59-66. PubMed ID: 30359874
[TBL] [Abstract][Full Text] [Related]
25. Fentanyl, fentanyl analogs and novel synthetic opioids: A comprehensive review.
Armenian P; Vo KT; Barr-Walker J; Lynch KL
Neuropharmacology; 2018 May; 134(Pt A):121-132. PubMed ID: 29042317
[TBL] [Abstract][Full Text] [Related]
26. Assessing the limit of detection of Fourier-transform infrared spectroscopy and immunoassay strips for fentanyl in a real-world setting.
McCrae K; Tobias S; Grant C; Lysyshyn M; Laing R; Wood E; Ti L
Drug Alcohol Rev; 2020 Jan; 39(1):98-102. PubMed ID: 31746056
[TBL] [Abstract][Full Text] [Related]
27. An LC-MS-MS Method for the Analysis of Carfentanil, 3-Methylfentanyl, 2-Furanyl Fentanyl, Acetyl Fentanyl, Fentanyl and Norfentanyl in Postmortem and Impaired-Driving Cases.
Sofalvi S; Schueler HE; Lavins ES; Kaspar CK; Brooker IT; Mazzola CD; Dolinak D; Gilson TP; Perch S
J Anal Toxicol; 2017 Jul; 41(6):473-483. PubMed ID: 28830122
[TBL] [Abstract][Full Text] [Related]
28. Case report: Etizolam and its major metabolites in two unnatural death cases.
Nakamae T; Shinozuka T; Sasaki C; Ogamo A; Murakami-Hashimoto C; Irie W; Terada M; Nakamura S; Furukawa M; Kurihara K
Forensic Sci Int; 2008 Nov; 182(1-3):e1-6. PubMed ID: 18976871
[TBL] [Abstract][Full Text] [Related]
29. Analysis of fentanyl analogs and novel synthetic opioids in blood, serum/plasma, and urine in forensic casework.
Moody MT; Diaz S; Shah P; Papsun D; Logan BK
Drug Test Anal; 2018 Sep; 10(9):1358-1367. PubMed ID: 29633785
[TBL] [Abstract][Full Text] [Related]
30. Analysis on dynamic changes of etizolam and its metabolites and exploration of its development prospect using UPLC-Q-exactive-MS.
Jie Z; Qin S; Liu F; Xu D; Sun J; Qin G; Hou X; Xu P; Zhang W; Gao C; Lu J
J Pharm Biomed Anal; 2024 Mar; 240():115936. PubMed ID: 38183733
[TBL] [Abstract][Full Text] [Related]
31. Development of an UPLC-MS/MS method for the analysis of 16 synthetic opioids in segmented hair, and evaluation of the polydrug history in fentanyl analogue users.
Ramírez Fernández MDM; Wille SMR; Jankowski D; Hill V; Samyn N
Forensic Sci Int; 2020 Feb; 307():110137. PubMed ID: 31927248
[TBL] [Abstract][Full Text] [Related]
32. Multiple fatalities in the North of England associated with synthetic fentanyl analogue exposure: Detection and quantitation a case series from early 2017.
Hikin L; Smith PR; Ringland E; Hudson S; Morley SR
Forensic Sci Int; 2018 Jan; 282():179-183. PubMed ID: 29216524
[TBL] [Abstract][Full Text] [Related]
33. Carfentanil - from an animal anesthetic to a deadly illicit drug.
Zawilska JB; Kuczyńska K; Kosmal W; Markiewicz K; Adamowicz P
Forensic Sci Int; 2021 Mar; 320():110715. PubMed ID: 33581655
[TBL] [Abstract][Full Text] [Related]
34. Detection of Carfentanil by LC-MS-MS and Reports of Associated Fatalities in the USA.
Shanks KG; Behonick GS
J Anal Toxicol; 2017 Jul; 41(6):466-472. PubMed ID: 28830120
[TBL] [Abstract][Full Text] [Related]
35. Paper spray mass spectrometry: A new drug checking tool for harm reduction in the opioid overdose crisis.
Vandergrift GW; Gill CG
J Mass Spectrom; 2019 Sep; 54(9):729-737. PubMed ID: 31432563
[TBL] [Abstract][Full Text] [Related]
36. Detection of synthetic cannabinoid adulteration in the unregulated drug supply in three Canadian settings.
Ti L; Tobias S; Maghsoudi N; Milloy MJ; McDonald K; Shapiro A; Beriault D; Stefan C; Lysyshyn M; Werb D
Drug Alcohol Rev; 2021 May; 40(4):580-585. PubMed ID: 33354869
[TBL] [Abstract][Full Text] [Related]
37. Emerging synthetic cannabinoids detected by a drug checking service in Toronto, Canada.
Scarfone KM; Maghsoudi N; McDonald K; Thompson H; Stefan C; Beriault DR; Werb D; Bowles JM
Clin Toxicol (Phila); 2022 Aug; 60(8):979-984. PubMed ID: 35546568
[TBL] [Abstract][Full Text] [Related]
38. [Comparison of four immunoassay screening devices for detection of benzodiazepine and its metabolites in urine: mainly detection of etizolam, thienodiazepine and its metabolites].
Namera A; Makita R; Nagao M
Chudoku Kenkyu; 2011 Mar; 24(1):27-34. PubMed ID: 21485120
[TBL] [Abstract][Full Text] [Related]
39. Etizolam: A rapid review on pharmacology, non-medical use and harms.
Nielsen S; McAuley A
Drug Alcohol Rev; 2020 May; 39(4):330-336. PubMed ID: 32243020
[TBL] [Abstract][Full Text] [Related]
40. Evidence for nonlinear accumulation of the ultrapotent fentanyl analog, carfentanil, after systemic administration to male rats.
Bergh MS; Bogen IL; Garibay N; Baumann MH
Neuropharmacology; 2019 Nov; 158():107596. PubMed ID: 30965021
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
